Basit öğe kaydını göster

Human Epidermal Growth Factor Receptor 2 Overexpression in Micropapillary and Other Variants of Urothelial Carcinoma

dc.contributor.authorYÖRÜKOĞLU, KUTSAL
dc.contributor.authorDemir, Hale
dc.contributor.authorBal, Nebil
dc.contributor.authorBehzatoglu, Kemal
dc.date.accessioned2021-03-05T12:18:53Z
dc.date.available2021-03-05T12:18:53Z
dc.date.issued2018
dc.identifier.citationBehzatoglu K., YÖRÜKOĞLU K., Demir H., Bal N., "Human Epidermal Growth Factor Receptor 2 Overexpression in Micropapillary and Other Variants of Urothelial Carcinoma", EUROPEAN UROLOGY FOCUS, cilt.4, ss.399-404, 2018
dc.identifier.issn2405-4569
dc.identifier.otherav_ac860e93-bb0b-4921-91e1-eb9a2776a9df
dc.identifier.othervv_1032021
dc.identifier.urihttp://hdl.handle.net/20.500.12627/115136
dc.identifier.urihttps://doi.org/10.1016/j.euf.2016.06.007
dc.description.abstractBackground: Human epidermal growth factor receptor 2 (HER2) protein overexpression or gene amplification has been shown in urothelial bladder cancer. This could be helpful when using targeted anti-HER2 therapy on these tumors.
dc.language.isoeng
dc.subjectSağlık Bilimleri
dc.subjectNefroloji
dc.subjectDahili Tıp Bilimleri
dc.subjectİç Hastalıkları
dc.subjectTıp
dc.subjectKlinik Tıp (MED)
dc.subjectKlinik Tıp
dc.subjectÜROLOJİ VE NEFROLOJİ
dc.titleHuman Epidermal Growth Factor Receptor 2 Overexpression in Micropapillary and Other Variants of Urothelial Carcinoma
dc.typeMakale
dc.relation.journalEUROPEAN UROLOGY FOCUS
dc.contributor.departmentIstanbul Bagcilar Training & Research Hospital , ,
dc.identifier.volume4
dc.identifier.issue3
dc.identifier.startpage399
dc.identifier.endpage404
dc.contributor.firstauthorID253193


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster